Skip to Content
Merck
CN

79224

1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one

≥96.0% (HPLC)

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C13H17N3O
CAS Number:
Molecular Weight:
231.29
EC Number:
213-819-5
UNSPSC Code:
12352100
PubChem Substance ID:
Beilstein/REAXYS Number:
617685
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

HTQWGIHCFPWKAS-UHFFFAOYSA-N

InChI

1S/C13H17N3O/c17-12-13(6-8-14-9-7-13)16(10-15-12)11-4-2-1-3-5-11/h1-5,14H,6-10H2,(H,15,17)

SMILES string

O=C1NCN(c2ccccc2)C13CCNCC3

assay

≥96.0% (HPLC)

mp

188-191 °C

storage temp.

2-8°C

Gene Information

Storage Class

13 - Non Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

H Onodera et al.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 8(4), 568-574 (1988-08-01)
Opioid ([3H]naloxone) and spirodecanone ([3H]spiperone) binding sites in the hippocampus were visualized in the Mongolian gerbil and in the rat using in vitro autoradiography. In the hippocampus, marked differences were noted in the stratum (sr.) pyramidale of the CA1 subfield
P M Laduron
Biochemical pharmacology, 37(1), 37-40 (1988-01-01)
In binding studies, stereospecificity is not a property restricted to receptor sites; indeed stereospecific binding has also been observed for acceptor sites. Therefore it does not represent a decisive criterion to make a binding site, a receptor site. However, in
F Murakami et al.
Pharmacology, 49(5), 286-295 (1994-11-01)
We investigated the effects of vinconate and pentobarbital against the alterations in spirodecanone binding in the gerbil striatum and hippocampus 5 h and 7 days after 10 min of cerebral ischemia, using receptor autoradiography. Vinconate and pentobarbital were given intraperitoneally
T Araki et al.
Neuroreport, 5(1), 37-40 (1993-10-25)
Using quantitative receptor autoradiography, spirodecanone binding was evaluated in the gerbil hippocampus 1 h-1 month after cerebral ischaemia of 10 min. The spirodecanone binding was unaffected in the hippocampus up to 48 h after ischaemia. Thereafter, increased binding was found
Differentiation of solubilized dopamine receptors from spirodecanone binding sites in rat striatum.
H Gorissen et al.
FEBS letters, 121(1), 133-138 (1980-11-17)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service